Raetz E, Beatty P G, Adams R H
Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, USA.
Bone Marrow Transplant. 1997 Sep;20(5):427-9. doi: 10.1038/sj.bmt.1700907.
Immunosuppressive therapy is commonly used in the management of autoimmune disorders. As marrow-derived lymphocytes appear to play a key role in these diseases, lymphoid ablation followed by replacement with autologous or allogeneic stem cells may be a therapeutic option. We report a 5-year-old boy with severe Evans syndrome which consists of immune thrombocytopenia and Coombs-positive hemolytic anemia. He was rendered into complete remission with marrow ablation followed by rescue with an HLA-identical sibling cord blood transplant. He unexpectedly died 9 months following transplant from acute hepatic failure of unknown etiology.
免疫抑制疗法常用于自身免疫性疾病的治疗。由于骨髓来源的淋巴细胞似乎在这些疾病中起关键作用,淋巴细胞清除后用自体或异体干细胞替代可能是一种治疗选择。我们报告一名5岁患有严重伊文氏综合征的男孩,该综合征包括免疫性血小板减少症和库姆斯阳性溶血性贫血。他在接受骨髓清除并随后接受人类白细胞抗原(HLA)匹配的同胞脐血移植挽救后完全缓解。移植后9个月,他意外死于病因不明的急性肝衰竭。